Asset Management and Custody Banks

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM)

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD 0.1603

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) released FY2025 Q3 earnings on November 12, 2025 (EST), actual revenue USD 0, actual EPS USD 0.0633

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) released FY2025 Q2 earnings on August 13, 2025 (EST) with actual revenue of USD 0 and EPS of USD 0

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) released FY2025 Semi-Annual Earnings on August 13 EST, with actual revenue of USD 0 and EPS of USD 0.097

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) released FY2025 Q1 earnings on May 13, 2025 (EST) with actual revenue of USD 0 and EPS of USD 0.074

Churchill Capital Corp IX released FY2024 Q4 earnings on March 31, 2025 (EST), with actual revenue of 0 USD and actual EPS of 0.0894 USD

Churchill Capital Corp IX released FY2024 earnings on March 31, 2025 (EST), with actual revenue of 0 USD and EPS of 0.3348 USD

Churchill Capital Corp IX released FY2024 Q3 earnings on November 13, 2024 (EST) with actual revenue of 0 USD and EPS of 0.0971 USD

Churchill Capital Corp IX released FY2024 Cumulative 3Q earnings on November 13, 2024 (EST), with actual revenue of 0 and EPS of 0.1711

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

Venus Concept

Jeffs Brands

Jaguar Health

TNL Mediagene

Baiya

Locafy

ImmunityBio

Painreform

Bristol-Myers Squibb Company

NeoVolta

CCIXW

LB filings

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD 0.02

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 0.07

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM)(CCIXW.US)

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD 0.02

CHURCHILL CAP CORP IX C/WTS 31/03/2031 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 0.07